Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Po-Chang Chiang

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Combinatorial Chemistry & High Throughput Screening|March 12, 2009
Simultaneous determination of LogD, LogP, and pK(a) of drugs by using a reverse phase HPLC coupled with a 96-well plate auto injectorPo-Chang Chiang, Yiding Hu
The AAPS Journal|August 15, 2013
Incorporation of physiologically based pharmacokinetic modeling in the evaluation of solubility requirements for the salt selection process: a case study using phenytoinPo-Chang Chiang, Harvey Wong
Journal of Pharmaceutical Sciences|January 24, 2024
Evaluating Utilization of Tiny-TIM to Assess the Effect of Food on the Absorptions of Oral Drugs and Its Application on Biopharmaceutical ModelingJia Liu, Karthik Nagapudi, Po-Chang Chiang
Pharmaceutical Research|April 27, 2022
Modeling Drug Dissolution in 3-Dimensional SpaceChi So, Po-Chang Chiang, Chen Mao
Journal of Pharmaceutical Sciences|December 28, 2020
Mechanistic Oral Absorption Modeling of Halofantrine: Exploring the Role of Intestinal Lymphatic TransportMichael J Dolton, Po-Chang Chiang, Yuan Chen
Journal of Drug Delivery|April 15, 2011
The impact of dosing interval in a novel tandem oral dosing strategy: enhancing the exposure of low solubility drug candidates in a preclinical settingPo-Chang Chiang, Sarah A South, Steve P Wene
Journal of Pharmaceutical Sciences|September 11, 2009
Combined use of pharmacokinetic modeling and a steady-state delivery approach allows early assessment of IkappaB kinase-2 (IKK-2) target safety and efficacyPo-Chang Chiang, Nandini N Kishore, David C Thompson
Journal of Pharmaceutical Sciences|May 31, 2016
Investigation of Dose-Dependent Factors Limiting Oral Bioavailability: Case Study With the PI3K-δ InhibitorPo-Chang Chiang, Daniel Sutherlin, Jodie Pang, et al.
Journal of Pharmaceutical Sciences|March 26, 2018
Exploring a Kinetic Model Approach in Biopharmaceutics: Estimating the Fraction Absorbed of Orally Administered Drugs in HumansPo-Chang Chiang, Jia Liu, Peter Fan, et al.
Molecular Pharmaceutics|April 25, 2013
Systemic concentrations can limit the oral absorption of poorly soluble drugs: an investigation of non-sink permeation using physiologically based pharmacokinetic modelingPo-Chang Chiang, Hank La, Haiming Zhang, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Combinatorial Chemistry & High Throughput Screening|March 12, 2009
Simultaneous determination of LogD, LogP, and pK(a) of drugs by using a reverse phase HPLC coupled with a 96-well plate auto injectorPo-Chang Chiang, Yiding Hu
The AAPS Journal|August 15, 2013
Incorporation of physiologically based pharmacokinetic modeling in the evaluation of solubility requirements for the salt selection process: a case study using phenytoinPo-Chang Chiang, Harvey Wong
Journal of Pharmaceutical Sciences|January 24, 2024
Evaluating Utilization of Tiny-TIM to Assess the Effect of Food on the Absorptions of Oral Drugs and Its Application on Biopharmaceutical ModelingJia Liu, Karthik Nagapudi, Po-Chang Chiang
Pharmaceutical Research|April 27, 2022
Modeling Drug Dissolution in 3-Dimensional SpaceChi So, Po-Chang Chiang, Chen Mao
Journal of Pharmaceutical Sciences|December 28, 2020
Mechanistic Oral Absorption Modeling of Halofantrine: Exploring the Role of Intestinal Lymphatic TransportMichael J Dolton, Po-Chang Chiang, Yuan Chen
Journal of Drug Delivery|April 15, 2011
The impact of dosing interval in a novel tandem oral dosing strategy: enhancing the exposure of low solubility drug candidates in a preclinical settingPo-Chang Chiang, Sarah A South, Steve P Wene
Journal of Pharmaceutical Sciences|September 11, 2009
Combined use of pharmacokinetic modeling and a steady-state delivery approach allows early assessment of IkappaB kinase-2 (IKK-2) target safety and efficacyPo-Chang Chiang, Nandini N Kishore, David C Thompson
Journal of Pharmaceutical Sciences|May 31, 2016
Investigation of Dose-Dependent Factors Limiting Oral Bioavailability: Case Study With the PI3K-δ InhibitorPo-Chang Chiang, Daniel Sutherlin, Jodie Pang, et al.
Journal of Pharmaceutical Sciences|March 26, 2018
Exploring a Kinetic Model Approach in Biopharmaceutics: Estimating the Fraction Absorbed of Orally Administered Drugs in HumansPo-Chang Chiang, Jia Liu, Peter Fan, et al.
Molecular Pharmaceutics|April 25, 2013
Systemic concentrations can limit the oral absorption of poorly soluble drugs: an investigation of non-sink permeation using physiologically based pharmacokinetic modelingPo-Chang Chiang, Hank La, Haiming Zhang, et al.
Pageof 6